For Health Systems

40% of your eligible patients never get screened. That's millions in downstream revenue left on the table.

mPATH is a cancer screening navigation platform that closes the gap between identification and completed screening — driving HEDIS scores, Stars ratings, and service line revenue.

Published in JAMA

Peer-Reviewed Evidence

57%

Increase Over Baseline

10:1

Guaranteed ROI

Get Pricing

The Challenge

Screening programs generate lists. They don't generate completions.

HEDIS and Stars pressure is growing

Screening quality measures directly impact reimbursement. Declining rates affect payer contracts and CMS reporting.

Navigators can't scale to your population

At $80K–$100K per navigator handling 200–300 patients, the math doesn't work for populations of 50,000+.

EHR outreach generates opens, not completions

MyChart messages and reminder letters reach patients who are already engaged. The patients most overdue never enter the funnel.

Why mPATH

Not a reminder. A peer-reviewed behavioral intervention.

mPATH guides the full screening journey — education, motivation, eligibility verification, self-scheduling, and completion — via SMS. No app, no portal, no provider visit required. Built on 15 years of NCI research and validated in the largest randomized controlled trial of digital screening navigation.

57%

Increase in screening completion (JAMA RCT)

53%

Of patients self-order (no provider visit needed)

2-3 days

To deploy (no EHR integration project)

10:1 ROI

Guaranteed (or refund the difference)

Economic Impact

Each completed screening generates $2,350 in downstream revenue.

$2,350/screening × 2,000+ additional patients = $4.7M+ downstream revenue

vs. $200K–$250K platform fee

HEDIS Performance

Direct lift in cancer screening quality measures affecting reimbursement rates.

Stars Ratings

Improved member experience and clinical outcomes translate to better CMS Star scores.

Value-Based Contract Payments

Performance on screening targets triggers shared savings and bonus payments.

Cancer Center Service Line Revenue

More completed screenings = more detected cancers = more oncology referrals and procedures.

Reduced Navigation Costs

mPATH handles 95% of the outreach and follow-up, freeing navigators for complex cases.

How It Works

Upload a patient file. mPATH handles the rest.

Upload eligible patient list

CSV from any EHR. mPATH integrates with your data in minutes, not months.

mPATH navigates the full journey

Education, motivation, eligibility verification, and self-scheduling via SMS — all built on behavioral science.

Staff manage the queue

Patients who said yes flow into a queue. Documentation ready for scheduling and provider handoff.

Published Evidence

The most rigorously studied digital screening intervention available.

JAMA Randomized Controlled Trial

The largest and most rigorous study of digital cancer screening navigation. 26,000+ patients across 8 health systems. 57% increase in screening completion versus standard care.

Download Full Study

26,000+

Patients studied across 8 health systems

57%

Increase in screening completion

Annals of Internal Medicine

Secondary trial showing sustained impact

$6M+ NCI Funding

Federal research investment in mPATH technology

DiMe Seal

Digital Medicine Society approved